MainBoardListed
Emcure Pharmaceuticals Limited
Company websiteSize: ₹1,93,65,347 crore. Fresh issue: ₹79,46,231 crore. OFS: ₹1,14,28,839 crore.
When to apply: 03-07-2024 — 05-07-2024. Allotment: 08-07-2024. Listing: 10-07-2024. Note: OFS does not raise fresh capital for the company.
Start Date03-07-2024
End Date05-07-2024
Listing Date10-07-2024
Allotment Date08-07-2024
Current Price₹1,325.05
GMP₹300 (29.76%)
Lot Size14 Shares
Subscription68.4 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹960 - ₹1008
Pre Issue₹18,08,52,116
Post Issue₹18,87,88,623
Issue Size₹1,93,65,347
(aggregating up to 1952.03 Cr)
(aggregating up to 1952.03 Cr)
Fresh Issue₹79,46,231
(aggregating up to 800.58 Cr)
(aggregating up to 800.58 Cr)
Offer For Sale₹1,14,28,839
(aggregating up to 1151.45 Cr)
(aggregating up to 1151.45 Cr)
The Grey Market Premium (GMP) for Emcure Pharmaceuticals Limited is currently around ₹300 (29.76%). This indicates an estimated listing price of approximately ₹1,260 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
21 Nov 2025, 13:07 | ₹1,008 | ₹300 | ₹1,308 (29.76%) |
06 Mar 2025, 11:59 | ₹1,008 | ₹300 | ₹1,308 (29.76%) |
Financials overview in Crores
Here is a quick look at the recent financial performance of Emcure Pharmaceuticals Limited . The numbers below ( in Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|
EPS | 27.54 | 29.42 | 36.62 |
ROE | 16.90 | 21.20 | 33.23 |
ROCE | 19.37 | 22.01 | 29.69 |
RONW | 16.87 | 21.27 | 33.32 |
PRE IPO(PE) | 34.55 | 0 | 0 |
POST IPO(PE) | 36.07 | 0 | 0 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹388.41 | 74278.71 | 191.24 |
RETAIL | ₹679.71 | 5000.2 | 7.36 |
HNIs 2+ | ₹97.10 | 3704.52 | 38.15 |
HNIs 10+ | ₹194.20 | 10661.67 | 54.90 |
EMPLOYEES | ₹10.98 | 96.73 | 8.81 |
Total | ₹1,370.40 | 93741.83 | 68.40 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
HNIs (2-10L) | 4,587 | 1,67,799 | 36.58 |
RETAIL | 4,81,654 | 26,01,844 | 5.40 |
Total | 4,86,241 | 27,69,643 | 5.70 |
The IPO reservation for Emcure Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 28.34% | 38,53,234 |
HNI | 21.26% | 28,89,926 |
RETAIL | 49.60% | 67,43,160 |
Employee | 0.80% | 1,08,900 |
TOTAL | 100.00% | 1,35,95,220 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 14 | ₹14,112 | |
sHNI | 15 | 210 | ₹2,11,680 | |
bHNI | 994 | 994 | ₹10,01,952 |
Below you can find the official contact details of Emcure Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: investors@emcure.co.in
Phone: +91 20 3507 0033
Website: https://www.emcure.com/
Address: Plot No. P-1 and P-2,, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune -411 057